Friday, October 30, 2026

Back to today

From X

@StableBread

Fajasy on X

I listened to ~17 interviews with Jason Jessup, the CEO of Magna Mining $MGMNF (TSX: $NICU), from October 2025 to September 2026 (for my deep dive). For context, Magna owns McCreedy West, a producing copper mine in Sudbury, Ontario, plus Levack and Crean Hill, two past-producing mines it plans to restart. Here are the most important takeaways I got from those interviews: 1) Levack could be 2-3x McCreedy West: Jessup expects “possibly two to even three times” McCreedy West’s payable metal from Levack (The Resource Update, September 8). 2) R2 isn’t in Levack’s upcoming study: R2, a high-grade zone Magna found at Levack in 2025, could produce “10 to 15% copper equivalent material” even with 1-2 tons of waste mined per ton of vein (KE Report, July 10), 3-4.5x McCreedy West’s grades, and Jessup says the zone carries “no streams or royalties on the precious metals” (KE Report, April 20). 3) No more equity raises, he says: With CAD$140M coming from Alpayana, a private Peruvian mining group, for 19.9% of Magna, Jessup said “we could have five mines in production in 5 years and not have to ever do another financing again” (KE Report, July 10). 4) But three timelines moved back: (1) Levack commercial production went from “a good possibility” by the end of 2027 (KE Report, February 20) to 2028 (KE Report, July 10), (2) Crean Hill grid power from as early as Q1 2026 to Q4, and (3) the R2 resource estimate from the end of 2026 or start of 2027 to “potentially by the end of 2027” (Mining Stock Daily, August 13). 5) Skin in the game: Jessup says he owns ~10.6M shares, has “never sold a share,” and wants “a $5 billion company” by 2030 (Natural Resource Stocks, July 20), 6.5x Magna’s CAD$768M market cap at CAD$2.45/share. Levack’s PEA and Crean Hill’s pre-feasibility study are both due in October, and Jessup expects a formal Levack restart decision “shortly after seeing the PEA come out” (Mining Stock Daily, September 24). --- Link in bio to find the deep dive.

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

338 firms

Sectors

Ordered by how often our editor reaches for them.